Literature DB >> 13998272

Cellular resistance to viral infection, with particular reference to endogenous interferon.

R R WAGNER.   

Abstract

Entities:  

Keywords:  INTERFERON; VIRUS DISEASES

Mesh：

Substances：

Year:  1963        PMID： 13998272      PMCID： PMC441170          DOI： 10.1128/br.27.1.72-86.1963

Source DB:  PubMed          Journal:  Bacteriol Rev        ISSN： 0005-3678


× No keyword cloud information.
  65 in total

1.  Participation of deoxyribonucleic acid in the multiplication of influenza virus.

Authors:  R D BARRY; D R IVES; J G CRUICKSHANK
Journal:  Nature       Date:  1962-06-23       Impact factor: 49.962

2.  Alteration of cellular resistance to Sindbis virus in mixed cultures of human cells attributable to interferon.

Authors:  I GRESSER; J F ENDERS
Journal:  Virology       Date:  1962-04       Impact factor: 3.616

3.  A consideration of the mechanisms of resistance to viral infection based on recent studies of the agents of measles and poliomyelitis.

Authors:  J F ENDERS
Journal:  Trans Stud Coll Physicians Phila       Date:  1960-10

4.  Inhibition of the infectivity of poliovirus ribonucleic acid by an interferon.

Authors:  M HO
Journal:  Proc Soc Exp Biol Med       Date:  1961-07

5.  The prolonged persistence of western equine encephalomyelitis virus in cultures of strain L cells.

Authors:  V C CHAMBERS
Journal:  Virology       Date:  1957-02       Impact factor: 3.616

6.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

7.  The use of sodium dodecyl sulfate in studies on the interaction of poliovirus and HeLa cells.

Authors:  B MANDEL
Journal:  Virology       Date:  1962-06       Impact factor: 3.616

8.  Interference phenomena between animal viruses; a review.

Authors:  W HENLE
Journal:  J Immunol       Date:  1950-03       Impact factor: 5.422

9.  The role of interferon in vaccinia virus infection of mouse embryo tissue culture.

Authors:  L A GLASGOW; K HABEL
Journal:  J Exp Med       Date:  1962-03-01       Impact factor: 14.307

10.  Studies on persistent infections of tissue cultures. IV. Evidence for the production of an interferon in MCN cells by myxoviruses.

Authors:  W HENLE; G HENLE; F DEINHARDT; V V BERGS
Journal:  J Exp Med       Date:  1959-10-01       Impact factor: 14.307
View more
  12 in total

1.  SPECIFIC VIRAL INTERFERENCE IN HELA CELL CULTURES CHRONICALLY INFECTED WITH COXSACKIE B5 VIRUS.

Authors:  R L CROWELL
Journal:  J Bacteriol       Date:  1963-09       Impact factor: 3.490

Review 2.  CELLULAR SUSCEPTIBILITY TO ENTEROVIRUSES.

Authors:  C M KUNIN
Journal:  Bacteriol Rev       Date:  1964-12

3.  Production of interferon by alveolar macrophages.

Authors:  J D Acton; Q N Myrvik
Journal:  J Bacteriol       Date:  1966-06       Impact factor: 3.490

4.  A virus inhibitor circulating in the blood of chickens, induced by Francisella tularensis and Listeria monocytogenes.

Authors:  B Lukás; J Hrusková
Journal:  Folia Microbiol (Praha)       Date:  1967       Impact factor: 2.099

5.  Studies in histoplasmosis. 3. Cross reactions and characterization of Histoplasma and Blastomyces inhibitory factors.

Authors:  E M O'Hern
Journal:  Mycopathol Mycol Appl       Date:  1967-04-28

6.  Formation of tobacco mosaic virus in an animal cell culture.

Authors:  J G Atherton
Journal:  Arch Gesamte Virusforsch       Date:  1968

7.  Corticosteroids and varicella. Six-year experience in an asthmatic population.

Authors:  C J Falliers; E F Ellis
Journal:  Arch Dis Child       Date:  1965-12       Impact factor: 3.791

8.  Influence of statolon on resistance of mice to influenza.

Authors:  F F Pindak; J P Schmidt; J Z Kendrick
Journal:  Appl Microbiol       Date:  1969-08

9.  ISOLOGOUS INTERFERENCE WITH ULTRAVIOLET AND X-RAY IRRADIATED BACTERIOPHAGE T2.

Authors:  S B LEVY
Journal:  J Bacteriol       Date:  1964-06       Impact factor: 3.490

10.  INTERFERENCE INDUCED AGAINST VACCINIA IN AN ADENOVIRUS-RHF-1 SYSTEM.

Authors:  N KHOOBYARIAN
Journal:  J Bacteriol       Date:  1964-01       Impact factor: 3.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.